Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

112 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Per- and polyfluoroalkyl substances, epigenetic age and DNA methylation: a cross-sectional study of firefighters.
Goodrich JM, Calkins MM, Caban-Martinez AJ, Stueckle T, Grant C, Calafat AM, Nematollahi A, Jung AM, Graber JM, Jenkins T, Slitt AL, Dewald A, Cook Botelho J, Beitel S, Littau S, Gulotta J, Wallentine D, Hughes J, Popp C, Burgess JL. Goodrich JM, et al. Among authors: nematollahi a. Epigenomics. 2021 Oct;13(20):1619-1636. doi: 10.2217/epi-2021-0225. Epub 2021 Oct 21. Epigenomics. 2021. PMID: 34670402 Free PMC article.
Serum per- and polyfluoroalkyl substance concentrations in four municipal US fire departments.
Burgess JL, Fisher JM, Nematollahi A, Jung AM, Calkins MM, Graber JM, Grant CC, Beitel SC, Littau SR, Gulotta JJ, Wallentine DD, Hughes RJ, Popp C, Calafat AM, Botelho JC, Coleman AD, Schaefer-Solle N, Louzado-Feliciano P, Oduwole SO, Caban-Martinez AJ. Burgess JL, et al. Among authors: nematollahi a. Am J Ind Med. 2023 May;66(5):411-423. doi: 10.1002/ajim.23413. Epub 2022 Jul 21. Am J Ind Med. 2023. PMID: 35864570 Free PMC article.
Serum per- and polyfluoroalkyl substance concentrations and longitudinal change in post-infection and post-vaccination SARS-CoV-2 antibodies.
Hollister J, Caban-Martinez AJ, Ellingson KD, Beitel S, Fowlkes AL, Lutrick K, Tyner HL, Naleway AL, Yoon SK, Gaglani M, Hunt D, Meece J, Mayo Lamberte J, Schaefer Solle N, Rose S, Dunnigan K, Khan SM, Kuntz JL, Fisher JM, Coleman A, Britton A, Thiese MS, Hegmann KT, Pavuk M, Ramadan FA, Fuller S, Nematollahi A, Sprissler R, Burgess JL. Hollister J, et al. Among authors: nematollahi a. Environ Res. 2023 Dec 15;239(Pt 1):117297. doi: 10.1016/j.envres.2023.117297. Epub 2023 Oct 8. Environ Res. 2023. PMID: 37816422 Free article.
Comparison of Serum Per- and Polyfluoroalkyl Substances Concentrations in Incumbent and Recruit Firefighters and Longitudinal Assessment in Recruits.
Nematollahi AJ, Fisher JM, Furlong MA, Beamer PI, Goodrich JM, Graber JM, Calafat AM, Botelho JC, Beitel SC, Littau SR, Gulotta JJ, Wallentine DD, Burgess JL. Nematollahi AJ, et al. J Occup Environ Med. 2024 Mar 1;66(3):202-211. doi: 10.1097/JOM.0000000000003020. Epub 2023 Nov 3. J Occup Environ Med. 2024. PMID: 38013397
Safety and immunogenicity of COReNAPCIN, a SARS-CoV-2 mRNA vaccine, as a fourth heterologous booster in healthy Iranian adults: A double-blind, randomized, placebo-controlled, phase 1 clinical trial with a six-month follow-up.
Salehi M, Alavi Darazam I, Nematollahi A, Alimohammadi M, Pouya S, Alimohammadi R, Khajavirad N, Porgoo M, Sedghi M, Mahdi Sepahi M, Azimi M, Hosseini H, Mahmoud Hashemi S, Dehghanizadeh S, Khoddami V. Salehi M, et al. Among authors: nematollahi a. Int Immunopharmacol. 2024 May 17;134:112192. doi: 10.1016/j.intimp.2024.112192. Online ahead of print. Int Immunopharmacol. 2024. PMID: 38761778
Long-Term Major Adverse Cardiovascular Events in Patients with Moderate and Severe COVID-19: A Focus on Early Statin Use and Previous CVD.
Khosravi A, Ghodsi S, Memarjafari M, Nematollahi A, Sheikh-Sharbafan R, Sadre-Bafghi SA, Moosavi SV, Abdollahzadeh M, Jalali A, Moshkani Farahani M. Khosravi A, et al. Among authors: nematollahi a. J Tehran Heart Cent. 2023 Jul;18(3):183-195. doi: 10.18502/jthc.v18i3.14113. J Tehran Heart Cent. 2023. PMID: 38146416 Free PMC article.
112 results